Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
TBRG vs INVA vs PRGO vs HCKT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Drug Manufacturers - Specialty & Generic
Information Technology Services
TBRG vs INVA vs PRGO vs HCKT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Biotechnology | Drug Manufacturers - Specialty & Generic | Information Technology Services |
| Market Cap | $387M | $1.93B | $1.61B | $288M |
| Revenue (TTM) | $347M | $424M | $4.18B | $297M |
| Net Income (TTM) | $4M | $504M | $-1.82B | $14M |
| Gross Margin | 53.0% | 76.2% | 34.2% | 30.1% |
| Operating Margin | 6.0% | 14.8% | -4.1% | 10.5% |
| Forward P/E | 10.1x | 11.9x | 5.6x | 6.9x |
| Total Debt | $167M | $269M | $3.97B | $80M |
| Cash & Equiv. | $25M | $551M | $532M | $18M |
TBRG vs INVA vs PRGO vs HCKT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| TruBridge, Inc. (TBRG) | 100 | 116.5 | +16.5% |
| Innoviva, Inc. (INVA) | 100 | 163.2 | +63.2% |
| Perrigo Company plc (PRGO) | 100 | 21.4 | -78.6% |
| The Hackett Group, … (HCKT) | 100 | 82.7 | -17.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TBRG vs INVA vs PRGO vs HCKT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TBRG lags the leaders in this set but could rank higher in a more targeted comparison.
INVA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 18.5%, EPS growth 8.2%, 3Y rev CAGR 8.7%
- 94.9% 10Y total return vs HCKT's 0.9%
- Lower volatility, beta 0.13, Low D/E 22.9%, current ratio 14.64x
- Beta 0.13, current ratio 14.64x
PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- 9.8% yield, 10-year raise streak, vs HCKT's 4.1%, (2 stocks pay no dividend)
HCKT is the clearest fit if your priority is valuation efficiency.
- PEG 0.31 vs INVA's 1.15
- Lower P/E (6.9x vs 11.9x), PEG 0.31 vs 1.15
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.5% revenue growth vs PRGO's -2.8% | |
| Value | Lower P/E (6.9x vs 11.9x), PEG 0.31 vs 1.15 | |
| Quality / Margins | 118.9% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.13 vs PRGO's 1.18, lower leverage | |
| Dividends | 9.8% yield, 10-year raise streak, vs HCKT's 4.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +21.7% vs PRGO's -51.2% | |
| Efficiency (ROA) | 32.4% ROA vs PRGO's -19.8%, ROIC 14.2% vs 3.7% |
TBRG vs INVA vs PRGO vs HCKT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
TBRG vs INVA vs PRGO vs HCKT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INVA leads in 3 of 6 categories
PRGO leads 2 • TBRG leads 0 • HCKT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INVA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 14.1x HCKT's $297M. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, INVA holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $347M | $424M | $4.2B | $297M |
| EBITDAEarnings before interest/tax | $47M | $86M | $58M | $35M |
| Net IncomeAfter-tax profit | $4M | $504M | -$1.8B | $14M |
| Free Cash FlowCash after capex | $32M | $181M | $108M | $25M |
| Gross MarginGross profit ÷ Revenue | +53.0% | +76.2% | +34.2% | +30.1% |
| Operating MarginEBIT ÷ Revenue | +6.0% | +14.8% | -4.1% | +10.5% |
| Net MarginNet income ÷ Revenue | +1.3% | +118.9% | -43.5% | +4.7% |
| FCF MarginFCF ÷ Revenue | +9.1% | +42.8% | +2.6% | +8.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | +10.6% | -7.2% | -11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +4.0% | -56.4% | +54.5% |
Valuation Metrics
PRGO leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 6.9x trailing earnings, INVA trades at a 92% valuation discount to TBRG's 88.9x P/E. Adjusting for growth (PEG ratio), INVA offers better value at 0.67x vs HCKT's 1.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $387M | $1.9B | $1.6B | $288M |
| Enterprise ValueMkt cap + debt − cash | $529M | $1.7B | $5.1B | $349M |
| Trailing P/EPrice ÷ TTM EPS | 88.90x | 6.91x | -1.14x | 24.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.14x | 11.91x | 5.56x | 6.90x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.67x | — | 1.08x |
| EV / EBITDAEnterprise value multiple | 8.81x | 8.10x | 7.42x | 10.97x |
| Price / SalesMarket cap ÷ Revenue | 1.11x | 4.55x | 0.38x | 0.94x |
| Price / BookPrice ÷ Book value/share | 2.10x | 1.65x | 0.55x | 4.57x |
| Price / FCFMarket cap ÷ FCF | 10.85x | 9.88x | 11.12x | 8.87x |
Profitability & Efficiency
INVA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-51 for PRGO. INVA carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), TBRG scores 6/9 vs PRGO's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.5% | +46.5% | -50.7% | +15.8% |
| ROA (TTM)Return on assets | +1.1% | +32.4% | -19.8% | +7.0% |
| ROICReturn on invested capital | +7.8% | +14.2% | +3.7% | +16.4% |
| ROCEReturn on capital employed | +9.8% | +12.4% | +4.3% | +18.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.94x | 0.23x | 1.35x | 1.17x |
| Net DebtTotal debt minus cash | $142M | -$282M | $3.4B | $61M |
| Cash & Equiv.Liquid assets | $25M | $551M | $532M | $18M |
| Total DebtShort + long-term debt | $167M | $269M | $4.0B | $80M |
| Interest CoverageEBIT ÷ Interest expense | 1.31x | 63.45x | -7.20x | 37.81x |
Total Returns (Dividends Reinvested)
INVA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INVA five years ago would be worth $19,437 today (with dividends reinvested), compared to $3,986 for PRGO. Over the past 12 months, INVA leads with a +21.7% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors INVA at 25.0% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.3% | +14.7% | -13.5% | -41.0% |
| 1-Year ReturnPast 12 months | +1.1% | +21.7% | -51.2% | -50.3% |
| 3-Year ReturnCumulative with dividends | -0.5% | +95.2% | -58.1% | -31.0% |
| 5-Year ReturnCumulative with dividends | -17.4% | +94.4% | -60.1% | -18.8% |
| 10-Year ReturnCumulative with dividends | -36.0% | +94.9% | -77.7% | +0.9% |
| CAGR (3Y)Annualised 3-year return | -0.2% | +25.0% | -25.2% | -11.6% |
Risk & Volatility
Evenly matched — TBRG and INVA each lead in 1 of 2 comparable metrics.
Risk & Volatility
INVA is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TBRG currently trades 96.6% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.94x | 0.13x | 1.18x | 1.10x |
| 52-Week HighHighest price in past year | $26.68 | $25.15 | $28.44 | $26.29 |
| 52-Week LowLowest price in past year | $13.88 | $16.52 | $9.23 | $9.48 |
| % of 52W HighCurrent price vs 52-week peak | +96.6% | +90.7% | +41.2% | +43.4% |
| RSI (14)Momentum oscillator 0–100 | 82.2 | 39.9 | 60.9 | 28.9 |
| Avg Volume (50D)Average daily shares traded | 299K | 621K | 3.4M | 299K |
Analyst Outlook
PRGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TBRG as "Hold", INVA as "Buy", PRGO as "Hold", HCKT as "Buy". Consensus price targets imply 79.7% upside for HCKT (target: $21) vs -1.3% for TBRG (target: $25). For income investors, PRGO offers the higher dividend yield at 9.81% vs HCKT's 4.14%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $25.44 | $37.67 | $20.00 | $20.50 |
| # AnalystsCovering analysts | 22 | 10 | 36 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | — | +9.8% | +4.1% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 10 | 1 |
| Dividend / ShareAnnual DPS | — | — | $1.15 | $0.47 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +0.2% | 0.0% | +24.0% |
INVA leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
TBRG vs INVA vs PRGO vs HCKT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TBRG or INVA or PRGO or HCKT a better buy right now?
For growth investors, Innoviva, Inc.
(INVA) is the stronger pick with 18. 5% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Innoviva, Inc. (INVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TBRG or INVA or PRGO or HCKT?
On trailing P/E, Innoviva, Inc.
(INVA) is the cheapest at 6. 9x versus TruBridge, Inc. at 88. 9x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Hackett Group, Inc. wins at 0. 31x versus Innoviva, Inc. 's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TBRG or INVA or PRGO or HCKT?
Over the past 5 years, Innoviva, Inc.
(INVA) delivered a total return of +94. 4%, compared to -60. 1% for Perrigo Company plc (PRGO). Over 10 years, the gap is even starker: INVA returned +94. 9% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TBRG or INVA or PRGO or HCKT?
By beta (market sensitivity over 5 years), Innoviva, Inc.
(INVA) is the lower-risk stock at 0. 13β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 837% more volatile than INVA relative to the S&P 500. On balance sheet safety, Innoviva, Inc. (INVA) carries a lower debt/equity ratio of 23% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — TBRG or INVA or PRGO or HCKT?
By revenue growth (latest reported year), Innoviva, Inc.
(INVA) is pulling ahead at 18. 5% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, INVA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TBRG or INVA or PRGO or HCKT?
Innoviva, Inc.
(INVA) is the more profitable company, earning 63. 8% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus 8. 1% for PRGO. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TBRG or INVA or PRGO or HCKT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Hackett Group, Inc. (HCKT) is the more undervalued stock at a PEG of 0. 31x versus Innoviva, Inc. 's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Perrigo Company plc (PRGO) trades at 5. 6x forward P/E versus 11. 9x for Innoviva, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCKT: 79. 7% to $20. 50.
08Which pays a better dividend — TBRG or INVA or PRGO or HCKT?
In this comparison, PRGO (9.
8% yield), HCKT (4. 1% yield) pay a dividend. TBRG, INVA do not pay a meaningful dividend and should not be held primarily for income.
09Is TBRG or INVA or PRGO or HCKT better for a retirement portfolio?
For long-horizon retirement investors, Innoviva, Inc.
(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13)). Both have compounded well over 10 years (INVA: +94. 9%, TBRG: -36. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TBRG and INVA and PRGO and HCKT?
These companies operate in different sectors (TBRG (Healthcare) and INVA (Healthcare) and PRGO (Healthcare) and HCKT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TBRG is a small-cap quality compounder stock; INVA is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock; HCKT is a small-cap income-oriented stock. PRGO, HCKT pay a dividend while TBRG, INVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.